Approved for 10.5 EMDRIA Credits

This program (January 22 – February 5, 2026) will include remote and live learning on psychedelic medicines for therapeutic use (including FDA-approved Esketamine). Through lecture and practicum, participants will learn how to integrate EMDR Therapy with clients who have engaged in or are preparing to receive Ketamine treatment. EMDR therapy can potentiate psychedelic therapy, particularly in preparation for therapeutic psychedelic work and in follow-up integration sessions.

Presenters: Kate Becker, LCSW & Sharon Steckler, LCSW

EMDRIA is not involved with the registration of this event. Please click the Register Here button below to visit the registration website. If you have any questions regarding the training, please use the contact information available on that site.